U.S. Healthcare Services Stock News

Earlier this week, MACOM Technology Solutions Holdings reported fiscal Q3 earnings that met EPS forecasts and surpassed revenue expectations, alongside the retirement of long-serving board member Susan Ocampo and a stock sale by SVP Robert Dennehy totaling US$636,172 under a 10b5-1 trading plan. The company's results and leadership changes occurred as renewed optimism around artificial intelligence fueled sector gains, with analysts highlighting MACOM's five-year compound annual growth rate...

One and one Green Technologies (NasdaqCM:YDDL) recently completed its widely discussed initial public offering on the Nasdaq. The event drew attention as shares jumped sharply in both premarket and after-hours trading on debut. See our latest analysis for One and one Green Technologies. The early days of trading for One and one Green Technologies have been anything but quiet. Following its Nasdaq debut, the company’s share price surged for a 1-day share price return of 21.03%, propelled by a...

Qfin Holdings (QFIN) has drawn renewed investor attention after releasing its fiscal second quarter results, showing an 11% rise in consumers on its platform and solid growth in approved credit lines. This operational momentum is reflected in analyst sentiment. See our latest analysis for Qfin Holdings. Despite the upbeat report, Qfin Holdings' share price has pulled back sharply in recent months, with a 36% drop over the past 90 days and a year-to-date decline of 30%. Even so, the company’s...

Vail Resorts recently reported full-year earnings for fiscal 2025, outlined capital plans totaling up to US$254 million, announced Board refreshment with two long-serving directors stepping down at the next annual meeting, and reaffirmed its quarterly cash dividend of US$2.22 per share. An interesting detail is that Vail Resorts has emphasized both disciplined capital allocation, including future acquisition opportunities, and a continuation of shareholder returns through dividends and...

Everest Group (EG) has been on investors’ radar following recent shifts in its stock performance. The company’s shares have seen some fluctuation lately, prompting questions around valuation and future prospects as market sentiment adjusts. See our latest analysis for Everest Group. Everest Group’s share price has experienced a bumpy ride this year, dropping 4.6% year-to-date and recently dipping to $346.69. The bigger story, however, is the 1-year total shareholder return of -10%, which...

Thinking about what to do with Progressive’s stock right now? You are definitely not alone. With so much buzz around insurance companies and a share price that has put up some eye-popping long-term returns, Progressive is on the radar of a lot of investors trying to figure out if it is time to buy, sell, or just hold tight. Short-term, it has been a bit of a mixed bag. Over the last week, Progressive’s shares slipped 2.3%, while the past month brought a slightly larger dip of 3.3%. For 2024...

Apivia Courtage recently announced it will fully deploy SoundHound AI’s Amelia 7 agentic AI platform across its contact centers in a move to accelerate digital transformation and customer service automation. This collaboration builds on a successful pilot that delivered a 20% boost in productivity and showcases agentic AI’s potential for handling complex insurance queries. The expanded integration of Amelia 7 positions Apivia Courtage as an early adopter of advanced conversational AI in the...

NovoCure (NVCR) just announced that final results from its pivotal Phase 3 METIS trial for Tumor Treating Fields therapy in brain metastases from non-small cell lung cancer will be presented at a major industry conference and published in a top journal. See our latest analysis for NovoCure. While NovoCure’s latest trial update sparked interest, the company’s momentum has been mixed. After a challenging start to the year, share price rebounded with an 11% gain over the past month. However,...

Expedia Group (EXPE) made headlines by launching a suite of AI and machine learning-powered tools that boost efficiency and personalization for its partners. These innovations highlight the company’s ongoing push to stay ahead in travel technology. See our latest analysis for Expedia Group. These fresh product launches come at a time when Expedia Group’s momentum remains strong, even with recent volatility. The 1-year total shareholder return sits at an impressive 40.65%, while the latest...

NCR Voyix (VYX) has seen its stock come under some pressure recently, dropping around 12% over the past month. Investors are weighing ongoing business challenges against opportunities in its core markets, particularly following recent financial results. See our latest analysis for NCR Voyix. NCR Voyix’s 1-year total shareholder return sits at -16.2%, reflecting a wider loss of momentum that has gathered pace over recent weeks. While the stock’s sharp 12.6% drop this month follows a rocky run...

Sterling Infrastructure (STRL) has delivered an impressive run this year, with returns more than doubling since January. Investors are now watching to see if this momentum can continue as market dynamics change. See our latest analysis for Sterling Infrastructure. Sterling Infrastructure’s recent share price pullback has not slowed its spectacular momentum, with a 30-day share price return of 7.4% and a year-to-date gain of nearly 101%. Over the longer term, its 1-year total shareholder...

Earlier this month, MARA Holdings reported unaudited production of 736 Bitcoin for September 2025 and continued to attract attention for its expansion into AI infrastructure, European data centers, and energy operations. This ongoing pivot positions MARA Holdings at the intersection of cryptocurrency mining and AI-driven compute, fueling interest as the company adapts its business model to capitalize on the rising demand for energy-efficient, high-performance data centers globally. We’ll...

aTyr Pharma recently reported that its Phase 3 trial for efzofitimod in pulmonary sarcoidosis failed to meet its primary endpoint, leading to a wave of investor class action lawsuits alleging misleading statements about the drug’s efficacy. There is significant investor scrutiny on the company’s prior disclosures and communications, as legal investigations focus on the statements made during the trial period. We’ll examine how the trial failure and rising legal challenges may impact aTyr...

Regeneron Pharmaceuticals recently announced that the U.S. FDA approved Libtayo (cemiplimab-rwlc) as the first immunotherapy for adjuvant treatment of adult patients with cutaneous squamous cell carcinoma (CSCC) at high risk of recurrence following surgery and radiation, following evaluation under Priority Review and strong Phase 3 C-POST trial results. This approval introduces a new treatment option for earlier-stage high-risk CSCC patients and further consolidates Regeneron's oncology...

At a Special General Meeting held on October 7, 2025, SLB shareholders approved changing the company’s name from Schlumberger N.V. to SLB N.V. and adopted amendments making it easier to use "SLB Limited" and "SLB Ltd." in international transactions, with legal effectiveness starting the same day. This rebranding coincided with substantial contract wins, including an advanced technology and digital solutions award from Petrobras and the launch of a North Sea carbon storage project,...

On September 26, Starbucks announced a US$1 billion restructuring plan involving North American store closures and around 900 additional corporate job cuts, projecting a 1% decline in net unit growth for fiscal 2025. This substantial operational shift under CEO Brian Niccol is part of ongoing efforts to refocus resources and improve efficiency amid declining same-store sales and intensified competition. We’ll explore how Starbucks’ accelerated store downsizing shapes the company’s long-term...

In recent days, The Bank of New York Mellon Corporation announced a 19% increase in its annualized dividend amid analyst optimism for strong upcoming quarterly earnings, with the next earnings report scheduled for October 16, 2025. This move, alongside growing interest in blockchain innovation and tokenized deposits, highlights the company's efforts to modernize its payments infrastructure and meet evolving client needs. Investor sentiment has been further supported by the company’s track...

Cactus Inc recently reported its Q2 2025 earnings, with both earnings per share and revenue falling short of analyst expectations, prompting investor concern over its near-term financial outlook. This earnings miss has drawn renewed attention to the company's ability to manage costs and sustain growth amid ongoing industry headwinds and changing demand dynamics. We’ll explore how the recent Q2 earnings shortfall shapes Cactus Inc’s investment narrative and points to potential challenges...

Lamb Weston Holdings (NYSE:LW) has officially opened its new 40,000-square-meter production facility in Mar del Plata, Argentina, signaling a major step in its strategy to serve rising demand across Latin America, particularly in Brazil. See our latest analysis for Lamb Weston Holdings. These expansions arrive during a period of strengthening momentum for Lamb Weston Holdings. The 30-day share price return is nearly 13%, and gains over the past 90 days exceed 24%. Even so, the company’s...

Autohome (NYSE:ATHM) has caught the attention of investors recently, as its stock saw some movement over the past week. With this shift, many are wondering what could be influencing the shares right now and how fundamentals may come into play. See our latest analysis for Autohome. After rallying earlier in the year, Autohome’s momentum has cooled recently, with a string of negative share price returns in the past week and month. This echoes a broader struggle seen in its 1-year total...

Triumph Financial (TFIN) has caught investor attention recently, with its stock sliding over the past month. Shares have dropped around 21% since mid-June, prompting some to consider whether the current price presents a value opportunity. See our latest analysis for Triumph Financial. The sharp 21% slide in Triumph Financial's share price over the last month comes after a year already marked by fading investor confidence and mounting concerns about growth and risk. With a 47.1% share price...

Airbnb (ABNB) shares have moved lower over the past month, capturing the attention of investors tracking the travel platform’s performance. With the stock down 15% across the past 3 months, market watchers are weighing valuation in relation to the company’s growth figures. See our latest analysis for Airbnb. Looking at the bigger picture, Airbnb’s share price return has lost momentum so far this year, with the recent dip amplifying a slow fade from earlier gains. While the 1-year total...

KLA (KLAC) has captured attention after its recent share price movements, drawing interest from investors evaluating its value amid ongoing market shifts. The company's performance sparks fresh conversations about its earnings trajectory and growth prospects in the semiconductor space. See our latest analysis for KLA. KLA’s share price has been on a rollercoaster lately, slumping 6.7% in a single day and 10.8% this past week, but still boasting a year-to-date share price return of over 54%...

In recent weeks, Centrus Energy announced plans to expand its uranium enrichment plant in Ohio, following a waiver from the U.S. Department of Energy permitting imports of low enriched uranium from Russia through 2027 and a new memorandum of understanding with Korean firms regarding facility investment. This expansion illustrates how international collaboration and regulatory flexibility are shaping the company's response to evolving nuclear energy policy and supply chain dynamics. We’ll now...